These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

657 related items for PubMed ID: 19520976

  • 1. Lack of phosphatidylethanolamine N-methyltransferase alters plasma VLDL phospholipids and attenuates atherosclerosis in mice.
    Zhao Y, Su B, Jacobs RL, Kennedy B, Francis GA, Waddington E, Brosnan JT, Vance JE, Vance DE.
    Arterioscler Thromb Vasc Biol; 2009 Sep; 29(9):1349-55. PubMed ID: 19520976
    [Abstract] [Full Text] [Related]

  • 2. Impaired phosphatidylcholine biosynthesis reduces atherosclerosis and prevents lipotoxic cardiac dysfunction in ApoE-/- Mice.
    Cole LK, Dolinsky VW, Dyck JR, Vance DE.
    Circ Res; 2011 Mar 18; 108(6):686-94. PubMed ID: 21273556
    [Abstract] [Full Text] [Related]

  • 3. Opposing effects of apolipoprotein m on catabolism of apolipoprotein B-containing lipoproteins and atherosclerosis.
    Christoffersen C, Pedersen TX, Gordts PL, Roebroek AJ, Dahlbäck B, Nielsen LB.
    Circ Res; 2010 May 28; 106(10):1624-34. PubMed ID: 20360257
    [Abstract] [Full Text] [Related]

  • 4. Effect of macrophage-derived apolipoprotein E on hyperlipidemia and atherosclerosis of LDLR-deficient mice.
    Shi W, Wang X, Wong J, Hedrick CC, Wong H, Castellani LW, Lusis AJ.
    Biochem Biophys Res Commun; 2004 Apr 23; 317(1):223-9. PubMed ID: 15047172
    [Abstract] [Full Text] [Related]

  • 5. Ces3/TGH deficiency improves dyslipidemia and reduces atherosclerosis in Ldlr(-/-) mice.
    Lian J, Quiroga AD, Li L, Lehner R.
    Circ Res; 2012 Sep 28; 111(8):982-90. PubMed ID: 22872154
    [Abstract] [Full Text] [Related]

  • 6. Acute elevation of plasma PLTP activity strongly increases pre-existing atherosclerosis.
    Moerland M, Samyn H, van Gent T, van Haperen R, Dallinga-Thie G, Grosveld F, van Tol A, de Crom R.
    Arterioscler Thromb Vasc Biol; 2008 Jul 28; 28(7):1277-82. PubMed ID: 18421000
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Plasma markers of cholesterol homeostasis and apolipoprotein B-100 kinetics in the metabolic syndrome.
    Chan DC, Watts GF, Barrett PH, O'Neill FH, Thompson GR.
    Obes Res; 2003 Apr 28; 11(4):591-6. PubMed ID: 12690090
    [Abstract] [Full Text] [Related]

  • 11. Hepatic Expression of PEMT, but Not Dietary Choline Supplementation, Reverses the Protection against Atherosclerosis in Pemt-/-/Ldlr-/- Mice.
    Zia Y, Al Rajabi A, Mi S, Ju T, Leonard KA, Nelson R, Thiesen A, Willing BP, Field CJ, Curtis JM, van der Veen JN, Jacobs RL.
    J Nutr; 2018 Oct 01; 148(10):1513-1520. PubMed ID: 30281112
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Divergent effects of the catalytic and bridging functions of hepatic lipase on atherosclerosis.
    Dichek HL, Qian K, Agrawal N.
    Arterioscler Thromb Vasc Biol; 2004 Sep 01; 24(9):1696-702. PubMed ID: 15205216
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. A gender-specific role for phosphatidylethanolamine N-methyltransferase-derived phosphatidylcholine in the regulation of plasma high density and very low density lipoproteins in mice.
    Noga AA, Vance DE.
    J Biol Chem; 2003 Jun 13; 278(24):21851-9. PubMed ID: 12668679
    [Abstract] [Full Text] [Related]

  • 17. Atheroprotective potential of macrophage-derived phospholipid transfer protein in low-density lipoprotein receptor-deficient mice is overcome by apolipoprotein AI overexpression.
    Valenta DT, Ogier N, Bradshaw G, Black AS, Bonnet DJ, Lagrost L, Curtiss LK, Desrumaux CM.
    Arterioscler Thromb Vasc Biol; 2006 Jul 13; 26(7):1572-8. PubMed ID: 16675720
    [Abstract] [Full Text] [Related]

  • 18. Serum amyloid A and lipoprotein retention in murine models of atherosclerosis.
    O'Brien KD, McDonald TO, Kunjathoor V, Eng K, Knopp EA, Lewis K, Lopez R, Kirk EA, Chait A, Wight TN, deBeer FC, LeBoeuf RC.
    Arterioscler Thromb Vasc Biol; 2005 Apr 13; 25(4):785-90. PubMed ID: 15692094
    [Abstract] [Full Text] [Related]

  • 19. Obesity potentiates development of fatty liver and insulin resistance, but not atherosclerosis, in high-fat diet-fed agouti LDLR-deficient mice.
    Coenen KR, Hasty AH.
    Am J Physiol Endocrinol Metab; 2007 Aug 13; 293(2):E492-9. PubMed ID: 17566116
    [Abstract] [Full Text] [Related]

  • 20. FXR deficiency causes reduced atherosclerosis in Ldlr-/- mice.
    Zhang Y, Wang X, Vales C, Lee FY, Lee H, Lusis AJ, Edwards PA.
    Arterioscler Thromb Vasc Biol; 2006 Oct 13; 26(10):2316-21. PubMed ID: 16825595
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 33.